VC
WST icon

Veracity Capital’s West Pharmaceutical WST Stock Holding History

Veracity Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-560
Closed -$230K – 234
2022
Q1 		$230K Sell
560
-695
-55% -$272K 0.1% 204
2021
Q4 		$589K Buy
1,255
+335
+36% +$144K 0.24% 107
2021
Q3 		$390K Buy
920
+48
+6% +$20.2K 0.17% 138
2021
Q2 		$313K Buy
872
+85
+11% +$28.1K 0.07% 194
2021
Q1 		$222K Buy
787
+13
+2% +$3.72K 0.1% 201
2020
Q4 		$219K Buy
+774
New +$217K 0.11% 192

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Veracity Capital's WST Position: Q2 2022 in Review

Veracity Capital sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 560 shares — an estimated $230K sold.

Veracity Capital first reported a position in WST in Q4 2020 and held it in 6 quarters. The position peaked at $589K in Q4 2021. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

  • Veracity Capital reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • Veracity Capital sold 560 West Pharmaceutical shares in Q2 2022, an estimated $230K.
  • Veracity Capital first reported a position in West Pharmaceutical in Q4 2020 and held it in 6 quarters.
  • Veracity Capital's West Pharmaceutical position peaked at $589K in Q4 2021.
  • 655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on Veracity Capital's 13F filing for Q2 2022, filed 18 Jul 2022.